Changes in the Intestinal Microbiome and Alcoholic and Nonalcoholic Liver Diseases: Causes or Effects?

Gastroenterology

Volumn 150, Issue 8, 2016, Pages 1745-1755.e3

  Betrapally, Naga S ^a   Gillevet, Patrick M ^a   Bajaj, Jasmohan S ^b  

^a GEORGE MASON UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Diabetes; Dysbiosis; Intestinal Permeability; Metagenomics; Translocation

Indexed keywords

BILE ACID; FARNESOID X RECEPTOR; GASTROINTESTINAL HORMONE;

ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; ARTICLE; BACTERIAL GENE; BACTERIAL TRANSLOCATION; DIGESTION; DISEASE COURSE; HUMAN; INTESTINE FLORA; LIVER CIRRHOSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PRIORITY JOURNAL; ALCOHOLIC FATTY LIVER; INTESTINE; LIVER; MICROBIOLOGY;

FATTY LIVER, ALCOHOLIC; GASTROINTESTINAL MICROBIOME; HUMANS; INTESTINES; LIVER; LIVER CIRRHOSIS; NON-ALCOHOLIC FATTY LIVER DISEASE;

EID: 84964263169     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2016.02.073     Document Type: Article

References (95)

1. B. Schnabl, and D.A. Brenner Interactions between the intestinal microbiome and liver diseases Gastroenterology 146 2014 1513 1524
2. P.J. Turnbaugh, and J.I. Gordon The core gut microbiome, energy balance and obesity J. Physiol 587 2009 4153 4158
3. J. Qin, F. Yang, A. Li, and et al. A human gut microbial gene catalogue established by metagenomic sequencing Nature 464 2010 59 65
4. A.S. Neish Microbes in gastrointestinal health and disease Gastroenterology 136 2009 65 80
5. J. Henao-Mejia, E. Elinav, C.A. Thaiss, and et al. The intestinal microbiota in chronic liver disease Adv Immunol 117 2013 73 97
6. J. Prawitt, and et al. Farnesoid X receptor deficiency improves glucose homeostasis in mouse models of obesity Diabetes 60 2011 1861 1871
7. A.A. Salyers, F. Gherardini, and M. O'Brien Utilization of xylan by two species of human colonic Bacteroides Appl Environ Microbiol 41 1981 1065 1068
8. V. Prabha, and M. Ohri Review: bacterial transformations of bile acids World J Microbiol Biotechnol 22 2005 191 196
9. H. Yadav, J.-H. Lee, J. Lloyd, and et al. Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion J Biol Chem 288 2013 25088 25097
10. P. Kurdi, K. Kawanishi, K. Mizutani, and et al. Mechanism of growth inhibition by free bile acids in lactobacilli and bifidobacteria J Bacteriol 188 2006 1979 1986
11. T. Inagaki, and et al. Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor Proc Natl Acad Sci U S A 103 2006 3920 3925
12. K.B. Islam, S. Fukiya, M. Hagio, and et al. Bile acid is a host factor that regulates the composition of the cecal microbiota in rats Gastroenterology 141 2011 1773 1781
13. G.E. Lim, and P.L. Brubaker Glucagon-like peptide 1 secretion by the L-cell the view from within Diabetes 55 2006 S70 S77
14. P.E. Dubé, and P.L. Brubaker Frontiers in glucagon-like peptide-2: multiple actions, multiple mediators Am J Physiol Endocrinol Metab 293 2007 E460 E465
15. X. Shi, and et al. Central GLP-2 enhances hepatic insulin sensitivity via activating PI3K signaling in POMC neurons Cell Metab 18 2013 86 98
16. R.E. Ley, and et al. Obesity alters gut microbial ecology Proc Natl Acad Sci U S A 102 2005 11070 11075
17. R.E. Ley, P.J. Turnbaugh, S. Klein, and J.I. Gordon Microbial ecology: human gut microbes associated with obesity Nature 444 2006 1022 1023
18. X. Zhang, and et al. Human gut microbiota changes reveal the progression of glucose intolerance PLoS One 8 2013 e71108
19. J. Qin, and et al. A metagenome-wide association study of gut microbiota in type 2 diabetes Nature 490 2012 55 60
20. F.H. Karlsson, and et al. Gut metagenome in European women with normal, impaired and diabetic glucose control Nature 498 2013 99 103
21. H.J. Flint Obesity and the gut microbiota J Clin Gastroenterol 45 2011 S128 S132
22. C. Finelli, and G. Tarantino Is there any consensus as to what diet or lifestyle approach is the right one for NAFLD patients? J Gastrointest Liver Dis 21 2012 293 302
23. G. Wolf Gut microbiota: a factor in energy regulation Nutr Rev 64 2006 47 50
24. J.K. DiBaise, and et al. Gut microbiota and its possible relationship with obesity Mayo Clin Proc 83 2008 460 469
25. S.J. Kallus, and L.J. Brandt The intestinal microbiota and obesity J Clin Gastroenterol 46 2012 16 24
26. M. Kalliomäki, M.C. Collado, S. Salminen, and et al. Early differences in fecal microbiota composition in children may predict overweight Am J Clin Nutr 87 2008 534 538
27. P.D. Cani, and N.M. Delzenne The role of the gut microbiota in energy metabolism and metabolic disease Curr Pharm Des 15 2009 1546 1558
28. E. Vanni, and et al. From the metabolic syndrome to NAFLD or vice versa? Dig Liver Dis 42 2010 320 330
29. S. Bellentani, F. Scaglioni, M. Marino, and et al. Epidemiology of non-alcoholic fatty liver disease Dig Dis 28 2010 155 161
30. M.F. Gregor, and G.S. Hotamisligil Thematic review series: adipocyte biology. Adipocyte stress: the endoplasmic reticulum and metabolic disease J Lipid Res 48 2007 1905 1914
31. L. Zhu, and et al. Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH Hepatology 57 2013 601 609
32. J.J. Maher New insights from rodent models of fatty liver disease Antioxid Redox Signal 15 2011 535 550
33. M.A.R. Vinolo, H.G. Rodrigues, R.T. Nachbar, and et al. Regulation of inflammation by short chain fatty acids Nutrients 3 2011 858 876
34. H. Tilg Obesity, metabolic syndrome, and microbiota: multiple interactions J Clin Gastroenterol 44 Suppl 1 2010 S16 S18
35. J.S. Bajaj, and et al. Gut microbiota alterations can predict hospitalizations in cirrhosis independent of diabetes mellitus Sci Rep 5 2015 18559
36. J. Henao-Mejia, and et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity Nature 482 2012 179 185
37. A. Farhadi, and et al. Susceptibility to gut leakiness: a possible mechanism for endotoxaemia in non-alcoholic steatohepatitis Liver Int 28 2008 1026 1033
38. G. Szabo Gut-liver axis in alcoholic liver disease Gastroenterology 148 2015 30 36
39. S. Bala, M. Marcos, A. Gattu, and et al. Acute binge drinking increases serum endotoxin and bacterial DNA levels in healthy individuals PLoS One 9 2014 e96864
40. C.A. Rivera, B.U. Bradford, V. Seabra, and et al. Role of endotoxin in the hypermetabolic state after acute ethanol exposure Am J Physiol 275 1998 G1252 G1258
41. P. Chen, and et al. Microbiota protects mice against acute alcohol-induced liver injury Alcohol Clin Exp Res 39 2015 2313 2323
42. J.C. Bode, C. Bode, R. Heidelbach, and et al. Jejunal microflora in patients with chronic alcohol abuse Hepatogastroenterology 31 1984 30 34
43. I. Bjarnason, T.J. Peters, and R.J. Wise The leaky gut of alcoholism: possible route of entry for toxic compounds Lancet 1 1984 179 182
44. A. Keshavarzian, and et al. Leaky gut in alcoholic cirrhosis: a possible mechanism for alcohol-induced liver damage Am J Gastroenterol 94 1999 200 207
45. A. Parlesak, C. Schäfer, T. Schütz, and et al. Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease J Hepatol 32 2000 742 747
46. H. Fukui, B. Brauner, J.C. Bode, and et al. Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay J Hepatol 12 1991 162 169
47. Y.S. Roh, and E. Seki Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis J Gastroenterol Hepatol 28 Suppl 1 2013 38 42
48. E.A. Mutlu, and et al. Colonic microbiome is altered in alcoholism Am J Physiol Gastrointest Liver Physiol 302 2012 G966 G978
49. S. Leclercq, and et al. Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity Proc Natl Acad Sci U S A 111 2014 E4485 E4493
50. L.M. Napolitano, and et al. Chronic ethanol intake and burn injury: evidence for synergistic alteration in gut and immune integrity J Trauma 38 1995 198 207
51. A.W. Yan, and et al. Enteric dysbiosis associated with a mouse model of alcoholic liver disease Hepatology 53 2011 96 105
52. E. Mutlu, and et al. Intestinal dysbiosis: a possible mechanism of alcohol-induced endotoxemia and alcoholic steatohepatitis in rats Alcohol Clin Exp Res 33 2009 1836 1846
53. L. Bull-Otterson, and et al. Metagenomic analyses of alcohol induced pathogenic alterations in the intestinal microbiome and the effect of Lactobacillus rhamnosus GG treatment PLoS One 8 2013 e53028
54. G. Xie, and et al. Alteration of bile acid metabolism in the rat induced by chronic ethanol consumption FASEB J 27 2013 3583 3593
55. G. Kakiyama, and et al. Colonic inflammation and secondary bile acids in alcoholic cirrhosis Am J Physiol Gastrointest Liver Physiol 306 2014 G929 G937
56. V. Jaruvongvanich, S. Upala, and A. Sanguankeo Association between systemic inflammatory response syndrome and mortality in alcoholic hepatitis: a meta-analysis Hepatology 2015 Dec 8. http://dx.doi.org/10.1002/hep.28366
57. M. Llopis, and et al. Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease Gut 65 2016 830 839
58. J.S. Bajaj, and et al. Altered profile of human gut microbiome is associated with cirrhosis and its complications J Hepatol 60 2014 940 947
59. D.J. Drucker, and M.A. Nauck The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes Lancet 368 2006 1696 1705
60. S.L. Samson, and et al. Exenatide decreases hepatic fibroblast growth factor 21 resistance in non-alcoholic fatty liver disease in a mouse model of obesity and in a randomised controlled trial Diabetologia 54 2011 3093 3100
61. J.J. Wilkins, M. Dubar, B. Sébastien, and et al. A drug and disease model for lixisenatide, a GLP-1 receptor agonist in type 2 diabetes J Clin Pharmacol 54 2014 267 278
62. E. Sebokova, and et al. Taspoglutide, a novel human once-weekly analogue of glucagon-like peptide-1, improves glucose homeostasis and body weight in the Zucker diabetic fatty rat Diabetes Obes Metab 12 2010 674 682
63. R.B. Aguilar Evaluating treatment algorithms for the management of patients with type 2 diabetes mellitus: a perspective on the definition of treatment success Clin Ther 33 2011 408 424
64. X.-C. Wang, A.M. Gusdon, H. Liu, and et al. Effects of glucagon-like peptide-1 receptor agonists on non-alcoholic fatty liver disease and inflammation World J Gastroenterol 20 2014 14821 14830
65. A. Alisi, and et al. Randomised clinical trial: the beneficial effects of VSL#3 in obese children with non-alcoholic steatohepatitis Aliment Pharmacol Ther 39 2014 1276 1285
66. Z. Li, and et al. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease Hepatology 37 2003 343 350
67. J.R. Swann, and et al. Systemic gut microbial modulation of bile acid metabolism in host tissue compartments Proc Natl Acad Sci U S A 108 Suppl 1 2011 4523 4530
68. V.W.-S. Wong, and et al. Treatment of nonalcoholic steatohepatitis with probiotics. A proof-of-concept study Ann Hepatol 12 2013 256 262
69. H. Endo, M. Niioka, N. Kobayashi, and et al. Butyrate-producing probiotics reduce nonalcoholic fatty liver disease progression in rats: new insight into the probiotics for the gut-liver axis PLoS One 8 2013 e63388
70. C.J. Jin, C. Sellmann, A.J. Engstler, and et al. Supplementation of sodium butyrate protects mice from the development of non-alcoholic steatohepatitis (NASH) Br J Nutr 114 2015 1745 1755
71. Y.-Y. Ma, and et al. Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis World J Gastroenterol 19 2013 6911 6918
72. B.A. Neuschwander-Tetri, and et al. Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial Lancet 385 2015 956 965
73. Y. Adachi, L.E. Moore, B.U. Bradford, and et al. Antibiotics prevent liver injury in rats following long-term exposure to ethanol Gastroenterology 108 1995 218 224
74. Z. Zhou, and et al. A critical involvement of oxidative stress in acute alcohol-induced hepatic TNF-alpha production Am J Pathol 163 2003 1137 1146
75. I.A. Kirpich, and et al. Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study Alcohol 42 2008 675 682
76. V. Stadlbauer, and et al. Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis J Hepatol 48 2008 945 951
77. P. Chen, and et al. Supplementation of saturated long-chain fatty acids maintains intestinal eubiosis and reduces ethanol-induced liver injury in mice Gastroenterology 148 2015 203 214.e16
78. J. Boursier, and et al. The severity of NAFLD is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota Hepatology 63 2016 764 765
79. K. Das, and et al. Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease Hepatology 51 2010 1593 1602
80. J.G. Caporaso, and et al. QIIME allows analysis of high-throughput community sequencing data Nat Methods 7 2010 335 336
81. P.D. Schloss, and et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities Appl Environ Microbiol 75 2009 7537 7541
82. J.R. White, N. Nagarajan, and M. Pop Statistical methods for detecting differentially abundant features in clinical metagenomic samples PLoS Comput Biol 5 2009 e1000352
83. J.R. Cole, and et al. Ribosomal Database Project: data and tools for high throughput rRNA analysis Nucleic Acids Res 42 2014 D633 D642
84. N. Segata, and et al. Metagenomic biomarker discovery and explanation Genome Biol 12 2011 R60
85. Available: https://mbac.gmu.edu/galaxy. Accessed December 1, 2015.
86. M.G.I. Langille, and et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences Nat Biotechnol 31 2013 814 821
87. S. Abubucker, and et al. Metabolic reconstruction for metagenomic data and its application to the human microbiome PLoS Comput Biol 8 2012 e1002358
88. N. Segata, and et al. Metagenomic microbial community profiling using unique clade-specific marker genes Nat Methods 9 2012 811 814
89. T.J. Treangen, and et al. MetAMOS: a metagenomic assembly and analysis pipeline for AMOS Genome Biol 12 2011 1 25
90. S. Michail, and et al. Altered gut microbial energy and metabolism in children with non-alcoholic fatty liver disease FEMS Microbiol Ecol 91 2015 1 9
91. M. Raman, and et al. Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease Clin Gastroenterol Hepatol 11 2013 868 875 e1-3
92. N. Matsushita, and et al. Effect of lipopolysaccharide on the progression of non-alcoholic fatty liver disease in high caloric diet-fed mice Scand J Immunol 83 2016 109 118
93. D.E. Fouts, M. Torralba, K.E. Nelson, and et al. Bacterial translocation and changes in the intestinal microbiome in mouse models of liver disease J Hepatol 56 2012 1283 1292
94. H. Okubo, and et al. Mosapride citrate improves nonalcoholic steatohepatitis with increased fecal lactic acid bacteria and plasma glucagon-like peptide-1 level in a rodent model Am J Physiol Gastrointest Liver Physiol 308 2015 G151 G158
95. P. Chen, P. Stärkel, J.R. Turner, and et al. Dysbiosis-induced intestinal inflammation activates tumor necrosis factor receptor I and mediates alcoholic liver disease in mice Hepatology 61 2015 883 894